LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 86 filers reported holding LOXO ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $552,000 | -21.0% | 3,944 | -3.5% | 0.07% | +18.0% |
Q3 2018 | $699,000 | -1.4% | 4,089 | 0.0% | 0.06% | -11.6% |
Q2 2018 | $709,000 | +40.1% | 4,089 | -6.8% | 0.07% | +35.3% |
Q1 2018 | $506,000 | +37.1% | 4,386 | 0.0% | 0.05% | +15.9% |
Q4 2017 | $369,000 | -98.3% | 4,386 | -98.2% | 0.04% | -98.4% |
Q3 2017 | $21,960,000 | -40.9% | 238,386 | -48.6% | 2.79% | -51.6% |
Q2 2017 | $37,159,000 | +175.9% | 463,386 | +44.8% | 5.77% | +152.0% |
Q1 2017 | $13,466,000 | +557.8% | 320,000 | +327.4% | 2.29% | +351.7% |
Q1 2016 | $2,047,000 | -89.9% | 74,870 | -89.5% | 0.51% | -85.3% |
Q4 2015 | $20,230,000 | -24.4% | 711,067 | -53.6% | 3.45% | -36.2% |
Q3 2015 | $26,764,000 | -8.1% | 1,531,108 | -5.2% | 5.41% | +5.2% |
Q2 2015 | $29,120,000 | +107.8% | 1,615,081 | +43.5% | 5.14% | +75.4% |
Q1 2015 | $14,015,000 | +0.2% | 1,125,665 | -5.5% | 2.93% | +7.7% |
Q4 2014 | $13,991,000 | -10.6% | 1,190,702 | -0.1% | 2.72% | -16.2% |
Q3 2014 | $15,654,000 | – | 1,192,202 | – | 3.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 3,438,920 | $289,488,000 | 57.19% |
DAFNA Capital Management LLC | 296,000 | $24,917,000 | 13.42% |
Casdin Capital, LLC | 360,000 | $30,305,000 | 7.38% |
Opaleye Management Inc. | 176,300 | $14,841,000 | 4.75% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 574,495 | $48,361,000 | 1.84% |
SECTORAL ASSET MANAGEMENT INC | 152,185 | $12,811,000 | 1.60% |
AWM Investment Company, Inc. | 85,000 | $7,155,000 | 1.39% |
Eventide Asset Management | 285,000 | $23,991,000 | 1.25% |
Rock Springs Capital Management LP | 310,000 | $26,096,000 | 1.18% |
Crawford Lake Capital Management, LLC | 53,420 | $4,497,000 | 1.06% |